NEXGEL, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from NEXGEL, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Cash Cushion Ratio: Debt, after subtracting cash, is 1.2 times its market value (net debt). Lower than 95% of Healthcare companies in United States.
- Steadiness Ratio: Sales grew in 3 of the last 3 years; profit grew in 2 of 3. Steadier than 85% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
-7.0×Over the last 3 years operating cash was negative while the company kept spending on investment (capex).
Higher than 53% of Healthcare companies in United States.
Cash Locked Ratio
$13For every $100 of sales, $13 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $20 tied up three years earlier.
Less money tied up than 73% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
3/3 · 2/3Sales grew in 3 of the last 3 years; profit grew in 2 of 3.
Steadier than 85% of Healthcare companies in United States.
Growth Efficiency Ratio
$19Sales grew 458% in 3 years; of every extra $100 of sales, $19 became extra profit.
Higher than 50% of Healthcare companies in United States.
Asset Productivity Ratio
+458% / +1%In 3 years sales changed by +458% while total assets changed by +1%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
-13.2×Operating cash was negative last year, while some debt falls due within a year.
Higher than 52% of Healthcare companies in United States.
Cash Cushion Ratio
1.2× debtDebt, after subtracting cash, is 1.2 times its market value (net debt).
Lower than 95% of Healthcare companies in United States.
Tangible Assets Ratio
83%Of every $100 the company owns, $83 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 53% of Healthcare companies in United States.
Tangible Net Worth Ratio
59%Of every $100 of net worth, $59 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
More tangible than 51% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (13)
NEXGEL, Inc. made a loss over the last year. NEXGEL, Inc. owes $0.79 for every $1 it owns. NEXGEL, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossNEXGEL, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
0.47The share price is 0.47 times NEXGEL, Inc.'s book value per share, lower than 92% of Healthcare companies in United States.
Market cap
$2 MThe total market value of all of NEXGEL, Inc.'s shares at today's price (share price × number of shares), smaller than 97% of Healthcare companies in United States. PosiCap size class: Nano Cap.
Net worth (book value)
$5 MWhat NEXGEL, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$10.15Net worth divided by the number of shares. The share price of $4.76 is 0.5 times this, which is the P/B above.
Return on equity (ROE)
-115.1%NEXGEL, Inc. lost 115.1% of its shareholders' money over the last year, lower than 75% of Healthcare companies in United States.
Owes vs Owns
0.79×NEXGEL, Inc. owes $0.79 for every $1 it owns (moderate), higher than 77% of Healthcare companies in United States.
Dividend yield
NoneNEXGEL, Inc. does not currently pay a dividend.
Revenue growth
+31%Revenue rose 31% in the year to Dec 2025, and grew 77% a year on average over 3 years.
Profit growth
LossNEXGEL, Inc. made a loss in each of the last two years.
Profit margin
-26.3%NEXGEL, Inc. lost $26 for every $100 of revenue.
Interest cover
Not coveredNEXGEL, Inc.'s operating profit did not cover its interest costs in the year to Dec 2025.
Cash vs debt
Net debtNEXGEL, Inc. had $3 M more debt than cash (net debt) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For NEXGEL, Inc.: $2 M ÷ $5 M (30 Jun 2026) = 0.5.
What is NEXGEL, Inc.'s return on equity?
NEXGEL, Inc. lost 115.1% of its shareholders' money over the last year, lower than 75% of Healthcare companies in United States.
How much does NEXGEL, Inc. owe compared with what it owns?
NEXGEL, Inc. owes $0.79 for every $1 it owns (moderate), higher than 77% of Healthcare companies in United States.
Does NEXGEL, Inc. pay a dividend?
No. NEXGEL, Inc. does not currently pay a dividend.
Is NEXGEL, Inc.'s revenue growing?
Revenue rose 31% in the year to Dec 2025, and grew 77% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.